No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

FTG Adds Protections for its Wireless X-Ray Sensor

Editor: What To Know

  • , FTG’s Chief Clinical Officer adds, “The DC-Air™ is meeting or exceeding all expectations from a performance standpoint, so including coverage for these concerns was an easy way to cut the risk for offices that want to move up to this technology.
  • In a Twitter thread last week, FTG announced they would also be adding an option to extend the sensor’s warranty and replacement coverage out to 48 months at any point before the included 24-month warranty runs out.
  • The new x-ray sensor has been featured in dental publications and revealed at events since such as The Dental Festival in Miami, FL after it received acceptance of its FDA 510(k) Product Submission in July this year.

Freedom Technologies Group (FTG) announced new protections against accidental damage, loss, and theft for its wireless intraoral x-ray sensor, DC-Air™, to be included in the product’s standard warranty. The updated warranty now includes a deductible option for overnight replacement— something typically reserved for paid support models.

“A concern we hear a lot from doctors interested in the sensor is that their staff may drop it or walk off with it since it doesn’t have a wire,” says John Celigoy, FTG’s Chief Operating Officer. “The DC-Air has technologies like Bluetooth tracking and a new type of x-ray sensor technology that is far more durable than any other digital sensor, so we’ve seen these concerns do not reflect the actual experience of our users.”

The new x-ray sensor has been featured in dental publications and revealed at events since such as The Dental Festival in Miami, FL after it received acceptance of its FDA 510(k) Product Submission in July this year.

Robert Sachs, D.D.S., FTG’s Chief Clinical Officer adds, “The DC-Air™ is meeting or exceeding all expectations from a performance standpoint, so including coverage for these concerns was an easy way to cut the risk for offices that want to move up to this technology.”

In a Twitter thread last week, FTG announced they would also be adding an option to extend the sensor’s warranty and replacement coverage out to 48 months at any point before the included 24-month warranty runs out.

The updates to the included warranty are reported to be effective immediately and apply retroactively to all current users. In addition, the company is offering a risk-free trial of the sensor to dental offices.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy